"Latest Insights on Executive Summary Leukotriene Inhibitors Market Share and Size
The global leukotriene inhibitors market size was valued at USD 2.45 billion in 2024 and is expected to reach USD 3.97 billion by 2032, at a CAGR of 6.22% during the forecast period
The market insights gained through this keyword market research analysis report facilitate a more...
Leukotriene inhibitors (also called leukotriene receptor antagonists or leukotriene modifiers) are oral medications that block the action of leukotrienes—inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema. Key drugs include montelukast (Singulair – dominant), zafirlukast (Accolate), and zileuton (Zyflo – 5-lipoxygenase inhibitor). These...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt